|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.37 USD | +0.16% |
|
+3.44% | +13.56% |
| 13/06 | FDA clears first over-the-counter glucose monitor for children | RE |
| 11/06 | Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction | RE |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 29,083 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 12.35% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 28,714 | 27,836 | 26,729 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 9.56% | -3.06% | -3.97% |
| P/E Ratio | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.8x | 25.8x | 21.5x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.2x | 10.9x | 7.85x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.3x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.57x | 4.99x | 4.46x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.5x | 4.77x | 4.1x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.5x | 14.6x | 12.1x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.7x | 19.4x | 15.5x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.9x | 22.4x | 17.6x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.46% | 4.46% | 5.67% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,525 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,637 | 1,909 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,437 | 1,721 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -369.5 | -1,248 | -2,354 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 75.37 | 75.37 | 75.37 |
| Nbr of stocks (in thousands) | 3,87,688 | 3,86,258 | 3,86,374 | 3,90,595 | 3,90,016 | 3,85,873 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.79x | 5.5x | 17.54x | -.--% | 2.91TCr | |
| 22.18x | 3.29x | 12.35x | 2.89% | 15TCr | |
| 20.16x | 3.48x | 12.52x | 3.56% | 10TCr | |
| 36x | 8.9x | 23.96x | 1.07% | 5.52TCr | |
| 14.84x | 0.18x | 11.13x | 0.84% | 5.48TCr | |
| 36.44x | 2.93x | 10.05x | 2.63% | 4.03TCr | |
| 35.05x | 1.3x | 11.46x | 0.22% | 3.1TCr | |
| 39.05x | 6.75x | 24.36x | 0.27% | 2.32TCr | |
| 23.72x | 3.03x | 12.36x | 1.36% | 2.03TCr | |
| 23.02x | 3.32x | 11.92x | 1.27% | 2.02TCr | |
| Average | 28.13x | 3.87x | 14.76x | 1.41% | 5.31TCr | |
| Weighted average by Cap. | 25.60x | 3.71x | 14.03x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
